Browsing: AstraZeneca News

Biopharmaceutical company AstraZeneca has finalised its acquisition of Canadian cancer specialist Fusion Pharmaceuticals Inc for a total of $2.4bn (£1.88bn). Fusion Pharmaceuticals is a clinical-stage biopharmaceutical…